PharosAI, a UK cancer AI consortium, has received Innovate UK funding for a project called DESTINY that asks whether AI…
Chinese researchers layered machine learning, docking and dynamics simulation to find HY-18,623, a compound that hits two cancer-driving kinases at…
New screens show AI-designed minibinders hit PD-L1 but struggle on other cancer targets.
Tempus's PRISM2 foundation model matches or beats rivals on diagnostic and prognostic pathology tasks.